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Staphylococcus aureus toxin LukSF dissociates from
its membrane receptor target to enable renewed
ligand sequestration
Karita Haapasalo,*,†,1 Adam J. M. Wollman,‡,1 Carla J. C. de Haas,* Kok P. M. van Kessel,*
Jos A. G. van Strijp,* and Mark C. Leake‡,k,2
*Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands; †Department of
Bacteriology and Immunology, University of Helsinki, Helsinki, Finland; and ‡Department of Biology and kDepartment of Physics, Biological
Physical Sciences Institute, University of York, York, United Kingdom
ABSTRACT: Staphylococcus aureus Panton-Valentine leukocidin is a pore-forming toxin targeting the human C5a
receptor (hC5aR), enabling this pathogen tobattle the immune responsebydestroyingphagocytes through targeted
lysis. Themechanisms that contribute to rapid cell lysis are largelyunexplored.Here,we show that cell lysismaybe
enabled by a process of toxins targeting receptor clusters and present indirect evidence for receptor “recycling” that
allows multiple toxin pores to be formed close together. With the use of live cell single-molecule super-resolution
imaging, Fo¨rster resonance energy transfer and nanoscale total internal reflection fluorescence colocalization
microscopy, we visualized toxin pore formation in the presence of its natural docking ligand. We demonstrate
disassociation of hC5aR from toxin complexes and simultaneous binding of new ligands. This effect may free
mobile receptors to amplify hyperinflammatory reactions in early stages of microbial infections and have impli-
cations for several other similarbicomponent toxins and thedesignofnewantibiotics.—Haapasalo,K.,Wollman,A.
J. M., de Haas, C. J. C., van Kessel, K. P. M., van Strijp, J. A. G., Leake, M. C. Staphylococcus aureus toxin LukSF
dissociates from its membrane receptor target to enable renewed ligand sequestration. FASEB J. 33, 000–000 (2019).
www.fasebj.org
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Staphylococcus aureus causes diseases ranging from su-
perficial skin and soft tissue infections to severe invasive
diseases, such as osteomyelitis and necrotizing pneumo-
nia (1). During the 1960s, methicillin-resistant S. aureus
(MRSA) was identified as a nosocomial pathogen (2). In
the 1990s, infection of previously healthy, community-
dwelling individuals with MRSA was reported (3). Since
then, these community-associated MRSA have rapidly
emerged worldwide (4). Variants have also recently been
identified that have reduced susceptibility to the antibiotic
vancomycin (5), as well as complete resistance (6), and
these forms of S. aureus pose a significant threat to human
health. S. aureus and resistant variants have also evolved
adaptations to evade attack from cells of the human im-
mune system. However, the molecular processes that
underlie these strategies are underexplored in living cells.
There are compelling scientific and societalmotivations to
understand the mechanisms involved in immunogenic
evasion strategies of S. aureus.
In the early 1930s, Panton and Valentine described
a powerful leukocidal toxin produced by multiple
S. aureus isolates, now denoted Panton-Valentine leu-
kocidin (Luk; PVL), years later shown to be cytotoxic to
ABBREVIATIONS: CCR, C–C chemokine receptor; CD88, cluster of differ-
entiation 88; Ecb, extracellular complement binding; F(G130D), G130D
leukocidin component F; F(wt), wild-type Staphylococcus aureus leukocidin
F; FRET, Fo¨rster resonance energy transfer; GFP, green fluorescent pro-
tein; hC5aR, human C5a receptor; HEK, human embryonic kidney; HSA,
human serum albumin; Luk, leukocidin; mF, Staphylococcus aureus leu-
kocidin F mutant; mF*, labeled Staphylococcus aureus leukocidin F mutant;
mGFP, monomeric green fluorescent protein; MRSA, methicillin-resistant
Staphylococcus aureus; mS, Staphylococcus aureus leukocidin S mutant; mS*,
labeled Staphylococcus aureus leukocidin S mutant; MSD, mean squared
displacement; PDB ID, Protein Data Bank identification; PE, phycoery-
thrin; PFT, pore-forming toxin; PMN, polymorphonuclear cell; pRSET,
plasmid Restriction Enzyme T7 promoter; PSF, point spread function;
PVL, Panton-Valentine leukocidin; RPMI, Roswell Park Memorial In-
stitute; S(wt), wild-type Staphylococcus aureus leukocidin S; SSI, structural
similarity index; TIRF, total internal reflection fluorescence
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neutrophils, monocytes, and macrophages but not to
lymphocytes (7, 8). Themajorityof community-associated
MRSA isolates carry the genes encoding PVL, partially as
a result of the successful spread of the PVL carrying clone
USA300 in the United States (3, 4, 9, 10), rarely present in
hospital-acquired antimicrobial-resistant MRSA and
methicillin-susceptible S. aureus isolates. Based on epide-
miologic studies, PVL is associated with primary skin in-
fections in humans, osteomyelitis, and in particular, severe
necrotizing pneumonia (11, 12). Necrotizing pneumonia
is a severe complication caused by bacterial lung infection.
It is characterized bymassive recruitment of neutrophils
in the site of infection, diffuse pulmonary inflammation,
septic shock, and respiratory failure. Bothhost factors and
microbial virulence factors are thought to play an impor-
tant role in the inflammation; however, it is unknown how
the interplay between these 2 factors affects the severity of
the disease (13). The specificity to cell-surface receptors
makes it difficult to study the role of PVL in S. aureus
pathogenesis in a whole animal model. It is possible that
lysisofneutrophilsbyPVL is responsible fora reducedhost
defense response allowing the pathogen to spread and
cause eventual tissue damage. However, a previous study
using a rabbit animal model on necrotizing pneumonia
suggests that PVL itself directly or indirectly causes tissue
injury and by this way, induces local inflammation (14).
PVL is a prophage-encoded bicomponent, b-barrel
pore-forming toxin (PFT) comprising protein subunits
Luk components S and F (LukS and LukF, respectively).
Binding of LukS and LukF to the surface of target cells
induces formation of the pore; chemical and genetic
analysis suggests that the resulting complex consists of a
lytic pore-forming hetero-octamer (15, 16). Stoichiometric
analysis in vitro of this complex suggests it is an octamer of
4-plus-4subunits (17). In this complex, onlyLukS isknown
to interact with the human C5a receptor [hC5aR; cluster
of differentiation 88 (CD88)], a 7-transmembrane GPCR.
LukS targets at least the extracellularN terminus of hC5aR
(18, 19), similar to the chemotaxis inhibitory protein of
S. aureus, but may also interact with the transmembrane
receptor region (20). C5a is a powerful anaphylatoxin re-
leased during complement activation that is a powerful
first-line defense mechanism against invading pathogens.
Activation of complement on the target leads to a rapid
opsonization with C3b (21). Further activation of com-
plement leads to formation of C5a and membrane attack
complexes that are lytic for Gram-negative but not Gram-
positive bacteria (22, 23). Therefore, in defense against
Gram-positive bacteria, C3b opsonization, together with
attraction and activation of neutrophils via C5a–C5aR in-
teraction, is essential (24, 25). In severe cases, formation of
C5a can potentially lead to hyperactivation of the inflam-
matory response, an inability to regulate this potentially
fatal reaction, andeventuallyharmthehumanhost tissues.
Because of this strong proinflammatory activity, thera-
peutic interventions have recently focused on neutralizing
antibodies against C5a and C5aR as potential candidates
for the treatment of severe inflammatory conditions, such
as bacterial-induced sepsis (26, 27).
LukS binding to hC5aR inhibits C5aR binding,
which efficiently blocks neutrophil activation (18). LukS
receptor binding alone is not sufficient for cell lysis but
requires simultaneous interaction between the Luk
subunits and hC5aR. However, multiple possible
subunit and receptor combinations are theoretically
possible, and the spatiotemporal dynamics in func-
tional complexes in live cells among LukS, LukF, and
hC5aR is not yet known. In addition to PVL, S. aureus
can produce a number of other b-barrel PFTs with
varying receptor and cell-type specificities fromwhich
most of them are classified as bicomponent toxins, such
as PVL (28).
Development ofmethods to studydynamic processes
of pore formation by these toxins at a molecular level
may improve our understanding of the evolution of
bacterial virulence and human immunity. There are
several studies that have attempted to explain the func-
tion of bacterial PFTs, including structural and subunit
stoichiometry data from high-resolution X-ray crystal-
lography and single-molecule fluorescence microscopy
(17, 29, 30). However, these studies focused on pathogen
instead of host factors and were thereby limited in ex-
cluding the specific interaction between host cell recep-
tor and bacterial toxin component, the first step required
for toxin oligomerization on the host cell membrane and
the presence of the most potent factor mediating the in-
flammatory response via C5a recognition in the site of
infection (18).
Here, we used standard and single-molecule fluores-
cence detection with super-resolution localization mi-
croscopy (31) to determine protein complex assembly on
receptors in live and fixed cell membranes. We studied
human embryonic kidney (HEK) cellsmodified to express
monomeric green fluorescent protein (mGFP)-labeled
hC5aR, exposed to Alexa Fluor dye-labeled S. aureus
toxin components LukS and LukF and imaged using
standard total internal reflection fluorescence (TIRF) real-
time microscopy (Supplemental Fig. S1), allowing us to
monitor the spatiotemporal dynamics of receptor and
toxin molecules in the cell membrane. Our findings in-
dicate thatLukSbindson clusters ofmembrane-integrated
hC5aRs. The receptor-bound LukS then binds LukF
leading to the formation of a pore that is consistent with
previous stoichiometric studies. However, when LukF is
bound to the complex, we observe fewer colocalized
hC5aRs with toxin in fixed cells, more immobilized toxin
complexes in live cells, and a significantly reduced Fo¨rster
resonance energy transfer (FRET) signal, indicating, un-
expectedly, that pore formation leads to simultaneous
dissociationof the receptors fromthe complex. In addition,
our biochemical data suggest that the dissociated receptor
can then be available for additional LukS molecules or
the C5a generated during complement activation as a re-
sponse to LukS and LukF (LukSF)-mediated cell lysis.
Although indirect evidence, this new finding suggests that
a limitednumberof receptors canbe“recycled”asdocking
for further toxin. This ensures that a sufficient number of
pores will damage nearby phagocytic cells, particularly
important when high numbers of C5a anaphylatoxin
are blocking LukS, and potentially also enables a simul-
taneousC5a-mediated inflammatory responseonadjacent
cells.
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MATERIALS AND METHODS
Experimental model and subject details
PMN isolation, cell lines, and transfections
Human blood was obtained from healthy volunteers, and
the polymorphonuclear (PMN) cells were isolated by Ficoll/
Histopaque centrifugation (32). Informed consent was obtained
from all subjects in accordance with the Declaration of Helsinki
and the Medical Ethics Committee of the University Medical
Center Utrecht (METC-protocol 07-125/C; approved March 1,
2010). To ensure a truly monomeric state and prevent GFP-
mediated clustering of the receptor, a fusion construct of hC5aR
with the mGFP variant with the A206K mutation (also denoted
GFPmut3) (33, 34) was made at the C terminus (primers used
listed in Table 1; source data 2), or a sortase A lysine-proline-
x-threonine-glycine-glycine (LPXTGG) sequence was made in
the N terminus and cloned into plasmid IRES puromycin
(pIRESpuro) vectors (Table 1) by PCR. The amplification reac-
tion was performed in 3 separate amplification steps using
overlap extension PCR on hC5aR and mGFP templates. hC5aR
(accession number of hC5aR = NM_00173) was used as the
template using enzymes and purification kits, as previously
described. The clones were ligated into the vectors and trans-
ferred into TOP10 Escherichia coli-competent cells and then
amplified and sequenced similarly to the toxin clones previously
described. The pIRESpuro/hC5aR-mGFPvectorwas transfected
into HEK 293T cells (a HEK cell line; Thermo Fisher Scientific,
Waltham, MA, USA), stably expressing G protein Ga16, using
Lipofectamine-2000 reagent, according to the manufacturer’s
instructions (Thermo Fisher Scientific). After 24–48 h, transfected
cells were harvested with 0.05% trypsin. To obtain a uniform,
stable culture, cells were subcloned in a concentration of 0.5 cell/
well in a 96-well plate in DMEM (Lonza, Basel, Switzerland),
supplemented with 10% fetal calf serum (Thermo Fisher Scien-
tific) 100 U/ml penicillin/100 mg/ml streptomycin (Thermo
Fisher Scientific), 1 mg/ml hygromycin, and 250 mg/ml puro-
mycin. For N-terminal labeling of the sortase A recognition
sequence containing HEK cells with FITC were successfully
performed in 2 steps as previously described (35). The THP-1
humanmonocytic cell linewas grown in Roswell ParkMemorial
Institute (RPMI) 1640 medium (Thermo Fisher Scientific), sup-
plementedwith 1 timeGlutamax (Thermo Fisher Scientific), 10%
fetal calf serum (Thermo Fisher Scientific), 100 U/ml penicillin,
100 mg/ml streptomycin (Thermo Fisher Scientific), and 25 mM
HEPES (Thermo Fisher Scientific). Differentiation of THP-1
monocytes into macrophages was done by the incubation of
cells in themediumfor 48hwith 100ng/mlphorbol 12-myristate
13-acetate. Expression of hC5aRwas analyzed by the incubation
of cells in 50 ml RPMI (Thermo Fisher Scientific), supplemented
with 0.05% human serum albumin (HSA; Sanquin, Amsterdam,
The Netherlands), RPMI-HSA at 5 3 106 cell/ml concentration
for 45 min with phycoerythrin (PE)-conjugated anti-CD88 (BD
Biosciences, San Jose,CA,USA), anddetectedby flowcytometry.
The presence of mGFP or FITC-LPXTGwas detected directly by
flow cytometry.
Recombinant protein production and purification
Polyhistidine-tagged LukS and LukFwere cloned and expressed
using anE. coli expression system. Formaleimide-based labeling,
a single-cysteine mutation was designed to the LukS and LukF
components [S. aureus Luk S mutant (mS) and S. aureus Luk F
mutant (mF)] based on previous data and the crystal structure of
the octameric pore (29). An additional mutation Y113H was in-
cluded in LukS to facilitate oligomerization of the maleimide-
labeled protein (17). The target genes were amplified by PCR
(Table 1) from the wild-type sequences using Phusion High-
Fidelity DNA polymerase (Thermo Fisher Scientific) (18). The
PCR product was cloned into a slightly modified plasmid Re-
striction Enzyme T7 promoter (pRSET) expression vector
(Thermo Fisher Scientific), resulting in expression of proteins
TABLE 1. Cloning sequence details
Clone (restriction site) gBlock primer, 59–39
39mGFP(NotI)stop ATATGCGGCCGCTTATTTGTATAGTTCATCCATG
59KOZ-hC5aR(BamHI) ATATGGATCCGCCGCCACCATGAACTCCTTCAATTATAC
59hC5aR-mGFP AGACCCAGGCAGTGAGTAAAGGAGAAGAACTTTTC
39hC5aR-mGFP TCTCCTTTACTCACTGCCTGGGTCTTCTGGGCCATAG
59N-sor-hC5aR CGGGATCCGCCGCCACCATGCTACCCGAGACTGGAGGCGGAGGTGGCAACTCCTTCAATTATACCAC
39hC5aR-not ATATGCGGCCGCCTACACTGCCTGGGTCTTCTG
59LukF-K288C(BamHI) CGGGATCCGCTCAACATATCACACCTGTAAG
39LukF-K288C(NotI) ATATGCGGCCGCTTAGCTCATAGGATTTTTTTCCTTAGATTGAGTATCTATTAAGCAAACTGTATGATTTT
CCCAATC
39LukS-K281C(NotI) ATATGCGGCCGCTCAATTATGTCCTTTCACGCAAATTTCATGAGTTTTCC
59LukS-Y113H GTCAAACATTAGGTCATAACATAGGTGGTAATTTTAATAG
39LukS-Y113H TTACCACCTATGTTATGACCTAATGTTTGACTAAC
59LukS(BamHI) CGGGATCCAAAGCTGATAACAATATTGAG
F(G130D) gBlock
BamHI/NotI pRSET
B C-his overlap
CTTTAAGAAGGAGATATACATATGGGATCCCAACATATCACACCTGTAAGTGAGAAAAAGGTTGATGATAA
AATTACTTTGTACAAAACAACTGCAACATCAGATTCCGATAAGTTAAAAATTTCTCAGATTTTAACTTTT
AATTTTATTAAAGATAAAAGTTATGATAAAGATACATTAATACTCAAAGCTGCTGGAAACATTTATTCTG
GCTATACAAAGCCAAATCCAAAAGACACTATTAGTTCTCAATTTTATTGGGGTTCTAAGTACAACATTTC
AATTAATTCAGATTCTAATGACTCAGTAAACGTTGTAGATTATGCACCTAAAAATCAAAATGAAGAATTT
CAAGTACAACAAACGGTAGGTTATTCTTATGGTGGAGATATTAATATCTCTAACGGCTTGTCAGGTGATG
GTAATGGTTCAAAATCTTTTTCAGAGACAATTAACTATAAACAAGAAAGCTATAGAACTAGCTTAGATAA
AAGAACTAATTTCAAAAAAATTGGTTGGGATGTTGAAGCACATAAAATTATGAATAATGGTTGGGGACCA
TATGGCAGAGATAGTTATCATTCAACTTATGGTAATGAAATGTTTTTAGGCTCAAGACAAAGCAACTTAA
ATGCTGGACAAAACTTCTTGGAATATCACAAAATGCCAGTGTTATCCAGAGGTAACTTCAATCCAGAATT
TATTGGTGTCCTATCTCGAAAACAAAACGCTGCAAAAAAATCAAAAATTACTGTTACTTATCAAAGAGAA
ATGGATAGATATACAAACTTTTGGAATCAACTTCACTGGATAGGTAATAATTATAAAGATGAAAATAGAG
CAACTCATACATCAATTTATGAAGTTGATTGGGAAAATCATACAGTTAAATTAATAGATACTCAATCTAA
GGAAAAAAATCCTATGAGCGCGGCCGCACACCATCACCATCACCATTAA
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with an N-terminal 63HIS-tag. For LukF mutant G130D LukF
[F(G130D)], we used a gBlock (a custom double-stranded DNA
sequence via IntegratedDNATechnologies, Coralville, IA, USA)
to incorporate the LukF in the pRSET vector. Clones were se-
quenced toverify the correct sequence. The recombinantproteins
were expressed inRosetta-gami 2 (DE3) pLysSE. coliusing 1mM
isopropylthio-b-galactoside induction and isolated by a native
isolation method. The expressed proteins were purified
according to the manufacturer’s instructions (Thermo Fisher
Scientific) using 1ml nickel HisTrap and Superdex 75 HiLoad
columns (GE Healthcare Life Sciences, Marlborough, MA,
USA). Toxin components were labeled with either Cy3 (GE
Healthcare, Waukesha, WI, USA), Alexa Fluor 594 or Alexa
Fluor 647 C2 maleimide reagent, according to the manufac-
turer’s instructions (Thermo Fisher Scientific), resulting in
negligible unlabeled content. The labeling efficiency was
100%, as determined by protein concentrations using ab-
sorption at 280 nm and dye concentrations using absorption
at 650 nm by a Nanodrop ND-1000 spectrophotometer.
Method details
Binding assays
Binding of the maleimide-labeled proteins to PMN and HEK
cells was confirmed by flow cytometry. LukS-K281C-Y113H
(mS) or wild-type mS [S(wt)] was labeled with FITC, FITC-
S(wt), or Alexa Fluormaleimide 647- or 594-labeledmS (mS*).
For competition assays, 3 mg/ml of the labeled protein and
increasing concentration of non mS* or S(wt) were incu-
bated with isolated PMNs or HEK hC5aR-mGFP cells (5 3
106 cell/ml) in a total volume of 50 ml RPMI-HSA on ice. For
binding assays without competition, the cells were incubated
with an increasing concentration of labeled mF (mF*). After
30 min incubation on ice, cells were washed, fixed with 1%
paraformaldehyde, and analyzed by flow cytometry. HEK
cells transfected with the C–C chemokine receptor type 2
(CCR2) receptor were used as negative control for mS bind-
ing. To see inhibition of PE-anti-CD88 (BD Biosciences)
binding by S(wt) or C5a, hC5aR-expressing HEK cells were
first incubated with increasing concentrations of S(wt) or
C5a for 45 min at 4°C. Then, 2 ml anti-CD88/200,000 cells
was added and incubated as previously described. Cells
were washed once with RPMI-HSA, fixed with 1% para-
formaldehyde, and analyzed by flow cytometry. To detect
hC5aR dissociation using sublytic concentrations of LukSF,
hC5aR-expressing HEK cells were incubated with 100 nM
S(wt) for 45 min at 4°C. After washing the unbound S(wt)
sublytic concentrations ofwild typemF [F(wt)] were added to
the cells and incubated for 20 min at 37°C and 5% CO2 at-
mosphere. Percentages of lysed vs. nonlysed cells were mea-
sured by using 1 mg/ml DAPI (MilliporeSigma, Burlington,
MA, USA) in the reaction. For C5a-rebinding assay, 1mMC5a
(MilliporeSigma) was labeled with NT647, according to the
manufacturer’s instructions (NanoTemper Technologies,
Munich, Germany). Free label from the sample was removed
by 3 times centrifugation through Amicon Ultra 0.5 ml cen-
trifugal filters (MilliporeSigma). The hC5aR-expressingHEK cells
were incubatedwith 1mMS(wt) for 45min at 4°C.Afterwashing,
20 nMNT647-labeled C5a and increasing concentrations of F(wt)
were added to the cells and incubated for 20 min at 37°C and 5%
CO2 atmosphere. Cells werewashed oncewith RPMI-HSA, fixed
with 1% paraformaldehyde, and analyzed by flow cytometry.
Percentages of lysed vs. nonlysed cells were measured by using
1mg/mlDAPI in the reaction.S. aureus extracellular complement-
binding (Ecb)proteinwasusedas anegative control, as it interacts
with another cell-surface receptor, CR1 (36). Flow cytometry data
were analyzed using the FlowJo (Tree Star, Ashland, OR, USA)
v.10 software package.
Cell-permeability assays
IsolatedPMNsorHEKhC5aR-mGFP cells (53 106 cell/ml)were
exposed to labeled and unlabeled mixtures as appropriate for
mF/mS recombinant proteins at equimolar concentrations in a
volume of 50 ml RPMI-HSA with 1 mg/ml DAPI. Cells were
incubated for 30 min at 37°C with 5% CO2 and subsequently
analyzedby flowcytometry.Tocalculate the lysis time, cellswere
first incubatedwith 150 nMmS for 15min. Then, 600 nMmFwas
added and immediately subjected to flow cytometry analysis,
where the permeability was measured at several time points.
Cell lysis was defined as intracellular staining by DAPI. HEK
cells transfected with the human CCR2 receptor was used as a
negative control for toxin-mediated lysis. Statistical differences
between means of repeated experiments were calculated using
2-tailed Student t tests.
Ex vivo complement activation assay
To maintain complement activity, the blood samples were anti-
coagulated with lepirudin (Refludan, Schering, Berlin, Ger-
many). Increasing concentrations of S(wt)F(wt) or S(wt) (0–2000
nM) were incubated in full blood for 30 min at 37°C under con-
tinuous rotation (300 rpm).Complement activitywas stoppedby
adding 10 mM EDTA in the suspension, and the plasma was
separated from the blood cells by centrifugation at 5000 g. A 1:30
dilution of each plasma sample was analyzed by the MicroVue
SC5b-9 Plus Enzyme Immunoassay, according to the manufac-
turer’s instructions (Quidel, San Diego, CA, USA). One S. aureus
colony (1 3 108 cells) was used as a positive control for SC5b-9
formation. The bacteria were grown overnight on a blood agar
plate at 37°C 5% CO2 atmosphere.
Fluorescence microscopy
Cells were imaged using a Nikon A1R/Stormmicroscope using
a 3100 numerical aperture oil-immersion Nikon TIRF objective
lens. We used a TIRF microscopymodule and laser excitation at
wavelengths 488 nm (for mGFP), 561 nm (for Alexa Fluor 594),
and 647 nm (for Alexa Fluor 647) from a commercial multilaser
unit fiber coupled into the microscope, capable of delivering
maximum power outputs up to;200 mWwith a depth of pen-
etration in the range of ;100–130 nm for the TIRF excitation
evanescent field. Fluorescent images were acquired on an iXon+
512 electron-multiplying charge-coupled device camera detector
(Andor, Belfast, Northern Ireland) at amagnification of 150 nm/
pixel. Green and red channel images were obtained by imaging
through separateGFPorAlexa Fluor 647 filter sets. For high laser
excitation intensity single-molecule millisecond imaging, green
channel images to determine mGFP localization were acquired
continuously using 488 nm wavelength laser excitation over a
period of;5 min through a GFP filter set; then, the filter set was
manually switched to Alexa Fluor 647 for red channel image
acquisition continuously using 647 nm wavelength laser excita-
tion until complete photobleaching of the sample after 1–2 min.
Forphotobleaching, laser powers ranged between 15mW(Alexa
Fluor 647) and100mW(mGFP). For fixed cell analysis, cellswere
either incubated first with mS or mS*, washed and incubated
withmF ormF*, or incubated first justwithmS*withmF* absent
and then washed and fixed with 1% paraformaldehyde.
For fluorescence imaging, the HEK cells were grown on 0.1%
poly-L-lysine, which coated 8-well-chambered cover-glass slides
(Ibidi, Martinsried, Germany) in standard growth conditions
described above. To analyze the deposition of mS* on live cells,
the cells were first imaged in PBS buffer in the absence of toxin.
Here, a 256 3 256 pixel area covered ;1 cell per field of view.
Then, the cells were incubated for 2 min with 5 mg/ml Alexa
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Fluor 594 maleimide mS* in RPMI-HSA, and the cells were
carefully washed with PBS, keeping the imaging area and focus
constant. Because of the fast bleaching of the Alexa Fluor
647 label, a more stable Alexa Fluor 594 label was used for the
mS* deposition imaging. The deposition ofmS*was detected for
10 min, and the lysis of the cell was recorded for 15 min after
addition of 600 nM unlabeled mF. Cells were imaged in TIRF at
50 ms per frame with the laser automatically switched among
488nm/0.22mW,647nm/3mW,and561nm/3mWor488nm/
0.22 mW and 561 nm/3 mW.
FRET experiments
The Cy3mS* or nonlabeledmS, Cy3mF* or nonlabeledmF, or
Cy3 mF* and controls (only FITC-labeled cells or unlabeled
cells with only Cy3mS*) were incubated at 4°C for 30min and
then 10 min at 37°C, washed 2 times with RPMI-HSA, and
fixed as before. The cells were in PBS during imaging. FITC
experiments were performed using a Leica TCS SP5 micro-
scope, a 62 times oil-immersion objective lens, and FRET
Sensitized Emission Wizard in Leica Application Suite Ad-
vanced Fluorescence. Images were acquired using 488 and
543 nm wavelength lasers, a laser power of 27% 12.0 (A.U.),
and a scan size of 512 3 512, 800 ms, 50 ms per frame, beam
splitter triple dichroic 488/543/633.
FRET efficiency e was calculated using the donor, directly
excited acceptor, and donor excited acceptor intensity from n =
5–10 manual regions of interest inside cells for each experiment,
using the following formula (37):
e ¼ bðB2DÞ2 gA
A
where B = intensity signal, donor excited acceptor;D = intensity
signal, donor; A = intensity signal, directly excited acceptor; b =
calibration for ratio of measured intensities of Bdonor channel/
Adonor channel; and g = calibration for ratio ofmeasured intensities
of Bacceptor channel/Aacceptor channel.
Single-molecule imaging of live and fixed cells
GFP andAlexa Fluor 647 fluorescencemicrograph time series
of fixed and live cells were sampled taken at 20 ms per frame.
Green channel images were acquired continuously using 488
nmwavelength laser excitation over a period of;5min via the
GFP filter set. Then, the filter set was manually switched to
that for Alexa Fluor 647, and red channel images were ac-
quired continuously using 647-nm wavelength laser excita-
tion until complete photobleaching of the sample after
1–2 min. The step-wise, single-molecule fluorescence photo-
bleaching was analyzed both for live and fixed cells. For live
cell photobleaching analysis, the cells were incubated with
150 nM mS* or unlabeled mS, as required for ;15 min. After
washing with PBS, 600 nM mF* or unlabeled mF was added,
and the imaging was done immediately within 10–15 min. If
mF* was added, then the wells were washed with PBS before
analysis. Furthermore, samples with only mS and without
toxins were analyzed. For fixed cell analysis, the cells were
incubated first with mS or mS* for 30 min at +4°C in RPMI-
HSA, washed with the same buffer, and incubated for 10 min
at 37°C with mF or mF*, or the same protocol was followed
but using mS* alone with mF* absent. Then, the cells were
washed and fixed with 1% paraformaldehyde. One molar
mercaptoethylamine buffer was used for fixed cell analysis.
Photobleaching of recombinant mGFP and Alexa Fluor
647 mS* was also separately analyzed in a tunnel slide com-
prising 2 pieces of double-sided tape, forming a channel
sandwiched between a standard glass microscope slide and a
plasma cleaned coverslip. mGFP or Alexa Fluor 647 mS* So-
lutions (1mg/ml)were immobilized onto the coverslip coated
by anti-GFP or anti-His antibodies, with PBS washes in
between.
Quantification and statistical analysis
Binding and permeability assays
Statistical significance between repeated (n. 1) experimentswas
analyzed using 2-tailed Student’s t tests, where use of a standard
P, 0.05 threshold indicated statistical significance. Means6 SD
of repeated experiments are shown in error bars, unless indicated
otherwise.
Image analysis
Basic image extraction, cropping, and quantification were done
using NIS-Elements microscope imaging software and ImageJ
(U. S. National Institutes of Health, Bethesda, MD, USA; http://
rsb.info.nih.gov/ij/). More advanced focus tracking was done
using bespoke softwarewritten inMatLab (MathWorks, Natick,
MA, USA) (38), which enabled automatic detection and locali-
zation of individual fluorescent foci to within 40 nm lateral pre-
cision (Supplemental Fig. S4). The software identifies candidate
foci by a combination of pixel-intensity thresholding and image
transformation. The intensity centroid and characteristic in-
tensity, defined as the sum of the pixel intensities inside a 5-pixel
radius circular region of interest around the focus intensity cen-
troid minus the local background and corrected for non-
uniformity in the excitation field, are determined by repeated
gaussian masking. If the signal-to-noise ratio of a focus (the in-
tensityperpixel/background SDperpixel) is greater thanapreset
threshold, nominally here set at 0.4 based on prior simulations,
then it is accepted and fittedwith a 2-dimensional radial gaussian
function todetermine itswidth. Foci inconsecutive frameswithin
a single point spread function (PSF) width, and not different in
intensity orwidth by greater than a factor of 2, are linked into the
same track.
Focus intensity was used to quantify stoichiometry in-
formation.As fociphotobleachover timeduring continuous laser
excitation, their intensity falls in a stepwise manner as a result of
photobleaching of an integer number of fluorophore tags in each
sampling time window. With the quantification of the size of a
single step, the characteristic intensity of a single fluorophore can
be obtained and thus, the stoichiometry of the focus from its
initial intensity. The step size is found from the periodicity in the
distribution of focus intensities corroborated by the pairwise
distancedistributionof these intensities and theFourier spectrum
of the pairwise distance that contains peaks at the characteristic
intensity and harmonics atmultiples of this value (Supplemental
Fig. S4D, E).
Here, the copy number of hC5aR-mGFPwas comparatively
high, such that the TIRF images were initially saturated re-
garding pixel-intensity output. After;20 s of photobleaching,
the nonsaturated focus intensity values were fitted by an
exponential function that characterized the rate of intensity
decay, equivalent to an exponential photobleach time of;20 s,
and extrapolated back to 0 time to determine the initial focus
intensity (Supplemental Fig. S4F). TheAlexa Fluor 647 dye also
bleached during 647 nm wavelength laser excitation, but im-
ages were not initially saturated. Some images, which were
exposed to the 488 nm laser and then the 647-nm laser, were
also bleached by the 488-nmwavelength laser. In these images,
a fixed correction factor of 6 times, determined by comparing
with images exposed to the 647-nm laser first, was used. The
stoichiometry of each focus was then determined as the initial
intensity divided by the intensity of the appropriate single
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fluorescent dye tag (i.e., either mGFP or Alexa Fluor 647 in this
case).
We characterized the mobility of tracked foci by calculating
their mean squared displacement (MSD) as a function of time
interval (t). For each detected focus, the MSD was calculated
from the measured intensity centroid [x(t),y(t)] at time t, assum-
ing a focus track ofN consecutive image frames at a time interval
t = nDt, where n is a positive integer, and Dt is the frame in-
tegration time (here, 20 ms):
MSDðtÞ ¼MSDðnDtÞ ¼ 1
N2 12 n
3 +
N212n
i¼1
n
½xðiDtþ nDtÞ2 xðiDtÞ2
þ ½yðiDtþ nDtÞ2 yðiDtÞ2
o
¼ 4Dtþ 4s2
The lateral (xy) localization precision is given by s, which we
determine to be 40 nm. We fitted a straight line to each separate
MSD relation. Assuming a line fit has an optimized gradient g to
the first 4 points (defined as the first 3 measured MSD data
points for n = 1, 2, and 3, in addition to a fourth data corre-
sponding to n = 0, obtained from constraining the intercept
4s2 to within measurement error of the localization pre-
cision), then the estimated microscopic diffusion coefficient
D is g/4.Dt. For immobile foci, tracks were collated and
compiled to generate a mean MSD vs. t relation, which was
fitted to an asymptotic rising exponential function as an analyt-
ical model for confined diffusion of MSD plateau equal to L2/6,
where L is the effective confinement diameter (39), enabling us
to estimate the confinement diameter.
Colocalization analysis
The structural similarity index (SSI) was calculated on intensity-
normalized images using the in-built MatLab function based on
Wang et al. (40). This index uses a combined luminance, contrast,
and structural term, based on local means 6 SD and cross-
correlation to assess the similarity of images.
The extent of colocalization between red and green detected
foci was determined using a method that calculated the overlap
integral between each green and red focus pair whose centroids
werewithin;1 PSFwidth (;3 pixels).With the assumption that
2 normalized 2-dimensional gaussian intensity distributions g1
and g2 for green and red foci, respectively, centered around
ðx1; y1Þ with s width s1 and around ðx2; y2Þ with width s2, the
overlap integral n is analytically determined as:
n ¼ e½2Dr2/2ðs21þs22Þ
where:
Dr2 ¼ ðx12 x2Þ2 þ

y12 y2
2
We use a criterion of an overlap integral of 0.75 or above
to indicate putative colocalization (41), as this corresponds to a
focus centroid separation equivalent to the localization pre-
cision in this case. By quantification of the SD on the number of
detected foci in each channel, we estimate that the SE of coloc-
alization proportion under our typical imaging conditions is
;9%.
Random focus overlap models
We calculated the probability of focus overlap in a single color
channel by first estimating a sensible range of focus surface
densityn. For the lower limit,weused thenumber of focus tracks
detected in a 20 image frame time window, and for the upper
limit, we used the average measured value of the background-
corrected pixel intensity valuedivided by the intensity of a single
fluorophore (equivalent to ;1 mS* molecule per pixel). We
implemented these probability estimates into a surface density
model that assumed a random Poisson distribution for nearest-
neighbor separation (41–46). This model indicates that the
probability that a nearest-neighbor separation is greater thanw is
givenby exp(2pw2n). Theprobability of overlap for eachdensity
estimate (Supplemental Fig. S6) was convolved with a real mo-
lecular stoichiometry distribution and a gaussian function p(x) of
stoichiometry (x):
pðxÞ ¼ 2ps2 exp
 
2
ðx2 nÞ2
2s2
ﬃﬃﬃ
n
p
!
where s is the width of single fluorophore intensity distribution
(;0.7 molecules), and n is the real molecular stoichiometry. The
tetramer model assumes n = 4, and then all higher-order stoi-
chiometries are a result of overlapping PSFs. The tetramer olig-
omer molecule assumed an equal number of multimerized
tetramers up to 5, which gave the best fit to the data.
The same strategy was used to model the random overlap
probability for green and red color channel fluorescent foci in
dual color imaging experiments to assess the extent of apparent
colocalization as a result of random overlap between hC5aR and
mS*/mF*. The probability that a nearest-neighbor separation is
greater than w for foci of 2 different types is the same as a single
type multiplied by two-thirds (38).
Software
All of our bespoke software developed is freely and openly ac-
cessible via the SourceForge website (https://sourceforge.net/
projects/york-biophysics/) (47).
Statistical tests and replicates
All statistical tests used are 2-tailed unless stated otherwise. For
single-molecule TIRF imaging, each cell can be defined as a bi-
ologic replicate sampled from the cell population. We chose
sample sizes of 5–7 cells yielding thousands of foci, generating
reasonable estimates for stoichiometry and diffusion coefficient
distributions. Technical replicates are not possible with the irre-
versible photobleaching assay.
RESULTS
Maleimide-labeled LukSF mediates toxicity on
human PMN and HEK cells
To study LukSF pore formation on live cells using single-
molecule fluorescence microscopy, single cysteine substi-
tutions on the exposed surface of the cap domain of the
individual toxins (Supplemental Fig. S1B)—K288C on
LukF and K281C on LukS—were engineered to facilitate
maleimide labeling. These were denoted as the modified
protein mF or mS. A second substitution Y113H on LukS
waschosenon thestemdomain to facilitatepore formation
of the LukS mutant (mS), based on previous studies (17).
We compared the lytic activity of thesemutantswith their
unmodified wild-type equivalents by measuring PMN
membrane permeabilization after 30 min toxin exposure
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using the DNA-binding fluorescent dye DAPI by flow
cytometry.DAPIdoes not penetrate intact cellmembranes
and is therefore a good measure for cell permeability and
cell death. In this assay, each of the wild-type toxins was
replacedwith themodifiedproteineitherunlabeled (mFor
mS) or with a single Alexa Fluor 647 dye molecule label
(mF* or mS*; Fig. 1). All modified toxins induced PMN
permeabilization, reaching 100% at ;3 nM (Fig. 1A), in-
terchangeable with the wild-type equivalents. Only
maleimide-labeled LukF (mLukF) (mF*) lost activity and
required;30 nM to reach 100% permeabilization. As the
LukS component mediates the toxin recognition on the
target C5aR, we evaluated the binding potency of mS and
mS* on PMNs. In this assay, mS was able to inhibit the
interaction of FITC-labeled S(wt) on PMNs equally aswell
as the maleimide mS* (Fig. 1B).
The LukSF toxin is known to be specific toward human
cells expressing hC5aR, such as neutrophils, monocytes,
and macrophages, but does not lyse cells that do not ex-
press the receptor (18). To report on the spatiotemporal
localization of the receptor and for determination of the
subunit stoichiometry in any observed receptor clusters,
we prepared HEK cells expressing hC5aR with an mGFP
variant (bearing the obligate-monomer mutation A206K)
cloned in the C-terminal end of the receptor. This cell line
also forms a monolayer on the coverslip and can be used
for the introduction of a single dye on the cloned receptor,
requirements for TIRF, and single-molecule imaging. We
verified the specificity and activity of the mutated and
labeled toxins on the HEK-hC5aR cells. As expected, the
toxins lysed only cells expressing hC5aR, whereas control
hCCR2-expressing cells, which do not bind LukS (48),
remained intact. We did not observe any binding of mF*
on the same cells (Fig. 1C, D), which is consistent with
previous observations that LukF, in the absence of LukS,
does not interact with PMN (16). The unlabeled mS
Figure 1. Toxin functionality on
PMN and HEK cells. A) PMN
cell permeability in the pres-
ence of unlabeled LukSK281-
CY113H and LukFK288C (mS +
mF; number of biologic repli-
cates, n = 2), Alexa Fluor mS*
or mF*, and F(wt) or S(wt) (n =
1), compared with PMN cell
permeability of S(wt) and F(wt)
(n = 3). B) Inhibition of 3 mg/
ml FITC-labeled FITC-S(wt)
(n = 3) and mS* (n = 1) binding
to PMN cell by mS. Permeabil-
ity dose dependencies for A and
B are shown with a polynomial
spline ﬁt; statistical signiﬁcance
indicated between low (0.3 and
0.001 nM) and high (300 nM)
toxin concentrations using Stu-
dent’s t test. Error bars indi-
cate SD. C) Column indicating
binding responses for mF* on
hC5aR cells (n = 2). ***P ,
0.001, statistically signiﬁcant dif-
ference between mS* binding
on HEK-hC5aR cells compared
with HEK-CCR2 and mF* bind-
ing on these cells. D) Perme-
ability of hC5aR-transfected
HEK cells using unlabeled mS
andmF and Alexa Fluor mS* and
mF* compared with S(wt) and
F(wt) (n = 2). E) Inhibition of
3 mg/ml mS* binding by mS
on HEK-hC5aR cells (n = 3).
CCR2-transfected HEK cells
used as negative controls for
toxin binding and lysis in C and
D (n = 2) or 1 representative
experiment in C. Dose dependency shown with polynomial spline ﬁt. Statistical signiﬁcance calculated between low (0.3 and
0.001 nM) and high (300 nM) toxin concentrations using Student’s t test. F) Permeability response of hC5aR-transfected HEK
cells following incubation with unlabeled mS and Alexa Fluor maleimide mF* or toxins F(wt) and S(wt) (n = 3). Statistical
signiﬁcance calculated between 15 and 0 min time points using Student’s t test. Error bars indicate SD. Percentages of mean
ﬂuorescence intensity are shown as relative to the maximum intensity in each individual experiment (B, C, E). Permeability of the
cells was analyzed after 30 min incubation at +37°C, whereas the inhibition assays were analyzed after 45 min incubation at +4°C
(Supplemental Movie S3).
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inhibited binding of mS* in a dose-dependent fashion
(Fig. 1E). HEK cells transfected with hC5aR required
higher toxin concentrations for optimal binding and lysis
by mS + mF compared with PMN, which is in agreement
with previous data for the wild-type variants. An expla-
nation for this finding could be that PMNs also express
another ligand for LukS, C5LR (or C5aR2), and LukF (48,
49). It is known that C5aR expression levels are not stable
in neutrophils but can easily change in natural settings, for
example, as a response to increased C5a levels (50). We
found that the expression levels between unstimulated
PMNs and THP-1 monocytes were low (mean fluores-
cence intensity = 748 6 29 and 1322 6 74) and clearly
different from phorbol 12-myristate 13-acetate-stimulated
THP-1cells (mean fluorescence intensity=31676360) that
are known to be sensitive to LukSF pore formation (18).
Therefore,we examinedHEK cells as amodel cell to study
hC5aR-LukSF, although their relative receptor expression
levels (mean fluorescence intensity = 20,1556 1570) were
high with slight overlap with the expression levels of ac-
tivated cells (Supplemental Fig. S2).AshC5aRis expressed
at low levels in unactivated neutrophils, we used this cell
line as a model to study Luk–receptor interactions in
higher resolution and to exclude the effect of the LukS–
hC5aR2 interaction with the cells.
Tobeable toanalyze thedynamicsof receptorand toxin
interactions, we verified the conditions required for HEK
cell lysis in time in the presence of mF and mS. As the
maleimide mF* required higher concentrations for effi-
cient lysis ofHEKcells andbecause of the loss ofmolecules
during washing cycles, the assay was optimized to have
20-foldexcessofmF* (600nM).Followingpreincubationof
hC5aR-mGFP-expressing HEK cells with S(wt) or mS,
F(wt) or mF* was added, and the cellular uptake of DAPI
was measured by flow cytometry every 5 min. The toxins
F(wt) and S(wt) caused.80% cell toxicity within 10 min,
whereas closer to 20min was required for significant lysis
by the mF* and mS toxin combination (Fig. 1F).
We further confirmed cell lysis using our modified
toxins and receptor by live cell imaging. We first set the
conditions to facilitate data acquisition of dynamic events
involved in the formation of LukSF nanopores in hC5aR-
mGFP HEK cell membranes. We sampled every 2.5 s at
50ms exposure time per frame using standard (nonsingle
molecule) TIRF microscopy at very low excitation in-
tensity to prevent photobleaching. Cells were first imaged
in the absence of toxin. In the green channel, we observed
mGFP localization consistent with the cell membrane
manifest as relatively high apparent brightness toward the
cell boundaries consistentwith the cellmembrane curving
away from the microscope coverslip perpendicular to the
TIRF excitation field. Controlled addition of mS* (labeled
withAlexa Fluor 647) to the samplePetri dish, followedby
washing, while imaging simultaneously throughout,
resulted in similar localizationof thehC5aRandmS* (Fig. 2
and Supplemental Movie S1). We quantified this in im-
ages by calculating the SSI from intensity normalized
regions of interest at the cell periphery and center (Sup-
plemental Fig. S3) as a function of time. The SSI increased
rapidly at the periphery andmore slowly in the center, as
the edges aremore accessible to mS*. Further addition of
mF resulted in complete lysis of the cell, as defined by the
observation of explosive release of membrane vesicles,
after;15 min (Fig. 2 and Supplemental Movie S2) and a
decrease in the SSI at the periphery (Supplemental Fig.
S3B). We also observed hC5aR-GFP, mS* (Alexa647),
and mF* (Alexa594) together in 3 color experiments,
imaging cells after addition of toxins and washes until
the start of lysis (Fig. 2). Similar localization was in-
dicated by the high SSI among all 3 channels (Supple-
mental Fig. S3C and Supplemental Movie S3).
Single-molecule TIRF microscopy of live cells
indicates that the clustered C5aR binds LukS
with a tetrameric substructure
With the use of higher laser intensity, TIRF excitation en-
abled rapid millisecond single color channel sampling of
single fluorophores faster than their molecular mobility in
the cell membrane (51), confirmed by imaging antibody-
immobilized mGFP and Alexa Fluor dyes (Supplemental
Fig. S4). Imaging live hC5aR-mGFP cells in these condi-
tions saturated the camera charge-coupled device, but af-
ter 1–2 min of exposure, photobleaching was sufficient to
reduce intensity and allow us to observe several distinct,
mobile, circular fluorescent foci at a mean surface density
of;1/mm2 in themembrane regions that lie parallel to the
TIRF field away from the cell boundaries (Fig. 3A and
Supplemental Movie S4). We monitored the spatiotem-
poral dynamics of foci in the planar membrane regions
using automated tracking software (38), which allowed
foci to be tracked for up to 18 s to a spatial precision of;40
nm (52) below the diffraction limit, thus enabling super-
resolution localization data to be obtained. The measured
width of the focal waist (defined as the half-width at half-
maximum, determined from their pixel-intensity profile)
was in the range of 200–300 nm, consistent with the PSF
width of our microscope (Supplemental Fig. S4G). By use
of a step-wise photobleaching analysis, we estimated
stoichiometry values for all detected fluorescent foci by
using amethod that quantifies the initial unbleached focus
brightness anddivides this by themeasuredbrightness for
the relevant single-dye reporter molecule (Supplemental
Fig. S4) (53). These foci contained large numbers of re-
ceptors with a mean stoichiometry of ;180 (Fig. 3B and
Table 2). Addition of mS and mF increased the mean
stoichiometry by.50%, consistent with the toxin causing
receptor clustering.
The imaging of mS* incubatedwith hC5aR-mGFP cells
revealed distinct foci (Fig. 3A and Supplemental Movie
S5). The probability distribution of mS* stoichiometry
values in live cells in the absence ofmF is shown in Fig. 3C,
rendered using a kernel density estimation that generates
an objective distribution that does not depend on the size
and location of subjective histogram bins (54). We mea-
sured a broad range of stoichiometry values, spanning a
range from only a fewmS* molecules per focus to several
10s ofmolecules, with amean of;30molecules per focus.
Closer inspection of the stoichiometry values indicated an
underlying periodicity to their probability distribution,
which we investigated using Fourier spectral analysis
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(46). The resulting power spectrum (Fig. 3D) indicated a
fundamental peak equivalent to a stoichiometry of 3.9 6
0.2 molecules, suggesting that foci are composed of mul-
tiples of tetrameric mS* complexes with hC5aR.
Fluorescent foci, if separated by less than the
diffraction-limited PSF width of our microscope, are
detected as a single particle but with higher apparent
stoichiometry. Therefore, we tested the hypothesis
that the observedmS* focus stoichiometry distribution
could be explained by the random overlap of isolated
mS* tetramer foci. To do so, we modeled the nearest-
neighbor separations of individual mS* tetramers in
the cell membrane as a random Poisson distribution
(41) and used sensible ranges of tetramer surface
density based on our single-particle tracking results
(Supplemental Fig. S5). However, all random tetramer
overlapmodels thatwe explored showedpoor agreement to
the observed experimental stoichiometry distribution, but
we found that random overlap of multimers of tetramers
could account for the stoichiometry distribution well (Fig.
3E).Optimized fits indicated that the randomoverlapofmS*
foci with a stoichiometry in the range of 4–20moleculeswas
able to account best for the experimental data. As hC5aR is
clustered, this likelyaccounts for theclusteringofmS*butnot
its tetrameric periodicity. These results are consistent with
mS* binding to clusters of hC5aR with a bias toward tetra-
meric substructures.
We tested if there was a dependence of focus stoichio-
metry on incubation time with Luk. The acquirement
of a time course for mF* accumulation following pre-
incubation of cells with mS was not feasible, as unbound
mF* had to be washed from the sample to prevent a pro-
hibitively high fluorescent background. However, we
were able to acquire time courses in which mFwas added
tocells thathadbeenpreincubatedwithmS*. For these, the
mS* focus stoichiometry distribution was measured as a
function of time after mF addition for several different
fieldsofview, eachcontaining typically;5cells.We found
that the mean hC5aR focus stoichiometry indicated no
obvious correlation to mF incubation time (Fig. 3F); how-
ever, the mean mS* focus stoichiometry increased with
time (P, 0.05).
With the calculation of the MSD as a function of time
interval (t) for each tracked focus and fitting a line to the
first 4 points,we coulddetermine its apparentmicroscopic
diffusion coefficient (D). The distribution of D for hC5aR
andmS*/mF(Supplemental Fig. S6) hadsimilar lowvalue
peaks at ;0.05 mm2/s, consistent with immobile foci
Figure 2. Standard TIRF mi-
croscopy of LukS/F with
hC5aR on HEK cells. A, left)
TIRF image of hC5aR-mGFP
on the surface of a HEK cell
before addition of toxin; A,
right) zoom-ins of yellow,
dashed square (left) immedi-
ately following 2 min incuba-
tion with Alexa Fluor 647-
labeled LukSK281CY113H
[mS*(Alexa647)]. B) Equiva-
lent images of the same cell of
B after .15 min incubation
with LukFK288C (mF). C,
upper) TIRF image of coloc-
alization of Alexa Fluor
594- and Alexa Fluor 647
mF* and mS* [mF*(Alexa594)
and mS*(Alexa647)] with hC5aR-
mGFP on HEK cells; C, lower)
zoom-in of yellow, dashed
square (upper) with colocal-
ized foci indicated (arrows).
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tracked with our localization precision of 40 nm. Several
mobile foci were also seen (Supplemental Movies S6 and
S7), which diffused at rates up to;5 mm2/s. Based on the
measured width of the immobile peak width on these
distributions and informed by simulations of immobile
fociwith representative intensity andnoise (Supplemental
Fig. S6), we set a threshold of 0.12mm2/s to categorize foci
as either immobile, which indicated a mean D = 0.025 6
TABLE 2. Stoichiometry and microscopic diffusion coefﬁcient in live and ﬁxed cells
Type
Stoichiometry, mol
(mean 6 SD) Foci (n)
Mobile foci D, m2m/s
(mean 6 SD)
Immobile foci D, m2m/s
(mean 6 SD)
Live cells
C5a 185 6 224 5346 0.48 6 0.43 0.03 6 0.03
C5a + mLukS* 281 6 213 8272 0.49 6 0.42 0.02 6 0.03
C5a + mLukS* + mLukF 291 6 248 6605 0.46 6 0.42 0.03 6 0.03
C5a + mLukS + mLukF* 223 6 202 4981 0.47 6 0.40 0.02 6 0.03
mLukS* 29 6 22 999 0.44 6 0.45 0.03 6 0.03
mLukS* + mLukF 84 6 89 841 0.34 6 0.35 0.01 6 0.02
mLukS + mLukF* 6 6 4 557 0.40 6 0.44 0.02 6 0.03
Colocalized C5a
foci, n (/%)
C5a foci not
colocalized, n (%)
Stoichiometry of colocalized
C5a foci, mol (mean 6 SD)
Stoichiometry of C5a foci that
are not colocalized, mol
(mean 6 SD)
Fixed cells
C5a + mLukS* 89 (32) 193 (68) 36 6 26 35 6 24
C5a + mLukS* + mLukF 84 (7) 1079 (93) 37 6 25 32 6 24
C5a + mLukS + mLukF* 59 (83) 283 (17) 26 6 20 26 6 20
Colocalized Luk
foci, n (%)
Luk foci not
colocalized, n (%)
Stoichiometry of colocalized
Luk foci, mol (mean 6 SD)
Stoichiometry of Luk foci that
are not colocalized, mol
(mean 6 SD)
mLukS* 88 (7) 1198 (93) 72 6 47 61 6 44
mLukS* + mLukF 86 (88) 658 (12) 121 6 95 136 6 94
mLukS + mLukF* 60 (5) 1186 (95) 20 6 16 18 6 15
Figure 3. Single-molecule TIRF microscopy of hC5aR, LukS, and LukF in live cells. A) Images of HEK cells treated with
LukSK281CY113H (mS) and Alexa Fluor-labeled LukFK288C (mF*) showing brightﬁeld (left), hC5aR-mGFP (green), and mF*
(red). B–D) Probability distribution for stoichiometry of hC5aR in the absence and presence of Alexa Fluor mS* and mF* (B),
and of mS* foci (C), indicating tetramer periodicity (D) from Fourier spectral analysis. E) A random tetramer overlap model
cannot account for mS* experimental stoichiometry data (R2, 0), but a tetramer-multimer model results in excellent agreement
(R2 = 0.85). F) hC5aR and mS* stoichiometry as a function of incubation time. G) Proportion of immobile and mobile
colocalized foci in the presence and absence of mS and mF. Error bars show SEM from n = 5–15 image subregions (n = 20–30
cells,;1000–10,000 foci).
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0.030mm2/s,ormobile,which indicatedameanD=0.476
0.40 mm2/s (Table 2). Plots of the measured MSD vs. t
relations for mobile foci indicated a linear dependence
indicative of free Brownian (i.e., normal) diffusion,with no
measureable differences between the receptor alone and
the receptor bound to toxin. We also noted, qualitatively,
a broad trend for a decrease in diffusion coefficient with
an increase in receptor stoichiometry. Similar plots for
immobile foci indicated a more asymptotic dependence
consistent with confined diffusion (39) whose plateau
was equivalent to a confinement diameter of ;400 nm
(Supplemental Fig. S6) but again, with no measureable
difference between the bound and unbound receptor
populations. The relative proportion of mobile foci was
;35% of tracked foci for hC5aR, regardless of toxin, and
similar for mS in the absence of mF. Addition of mF,
however, caused adrop in themobile proportion of toxin
by a factor of ;3 (Fig. 3G), suggesting that LukF causes
insertion of the complex and because only mF*/mS*
were affected, a possible change in association of the
LukSF complex with hC5aR. An alternative explanation
could be that the reduction in mobility is because pores
are sticking to newly immobile receptors correlated to
toxin binding in some undetermined way; however, we
believe this is a less plausible explanation, as we ob-
serve an insensitivity in the proportion of the mobile
receptor population regarding addition of either toxin
component.
Single-molecule TIRF microscopy combined
with colocalization analysis of fixed cells
suggests that LukSF dissociates from
the receptor
As a result of the high image frame rate of single-molecule
TIRFmicroscopy,wewerenotable to imagesimultaneously
2 color channels on our microscope; rather, each channel
was imaged separately in the same cells. Therefore, to de-
termine whether the toxin remains bound to the receptor
and to quantify the relative stoichiometry of components,
we imaged fixed cells, halting cell lysis, using the same two
spectrallydistinct green/reddyes ofmGFPandAlexaFluor
647 to label receptor and toxin components, respectively, as
for the live cell experiments.We imagedcells incubatedwith
mS*, followed by incubation with mF (Fig. 4A), as well as
simultaneously withmS +mF* (Supplemental Fig. S7), and
observed foci with similar stoichiometries (Table 2) to live
cells but colocalizedwith hC5aR. The SSI valueswere lower
for these fixed cells (Supplemental Fig. S7) compared with
live cells. Approximately 32%of the hC5aR fociwere found
colocalized in the presence ofmS*, dropping to,10% in the
presence of mF (Fig. 4B). This low percentage was within
ourestimateof thedegreeof randomcolocalizationbetween
the green and red fluorophores, entirely down to chance,
of;10%. This suggests that in the presence ofmF, the toxin
is not colocalized with the receptor and that mF causes
disassociation from hC5aR. The SSI values also dropped in
the presence of mF (Supplemental Fig. S8), consistent with
this hypothesis. The stoichiometry values for detectedgreen
hC5aR-mGFP foci were calculated and plotted against the
equivalent stoichiometryestimates for colocalizedred fociof
Figure 4. Relative stoichiometry of hC5aR, LukS, and LukF in
ﬁxed cells. A) Micrographs of ﬁxed hC5aR-mGFP HEK cells
treated with LukSK281CY113H (mS) and LukFK288C (mF)
showing hC5aR-mGFP (left), Alexa Fluor 647 (Ao¨exa647,
middle), and merge (right) on Alexa Fluor mS* with zoom-in
(lower panels) showing colocalized foci. B) Proportion of
colocalized foci treated with mS, mS* + mF, and mS + mF* for
hC5aR. Error bars show SEM from n = 4 image subregions (n ;
1000 foci). C) Heatmap of correlation between hC5aR and mS
stoichiometry (red, dashed line indicates 4 mS per hC5aR
molecule); R2 ; 0.15 (n ; 1000 foci from ; 10 cells). D, E)
FRET images and efﬁciencies. The FRET experiment was
performed in live and ﬁxed sortase-tagged FITC-hC5aR-
expressing cells. Live cells (number of biologic replicates, n = 2)
were incubated in the presence of Cy3 mS* for 1 h at +4°C and
washed, after which, unlabeled mF was added. FRET was
analyzed before (mS*) or after (mS* + mF) addition of mF.
FRET from ﬁxed cells (n = 3) was analyzed in the presence of
mS* or unlabeled mS and Cy3 mF* (n = 2). Statistical signiﬁcance
between cells with only mS and both of the toxin components,
mS and mF, was analyzed using Student’s t test. Error bars
indicate SD.
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mS* and mF*, respectively (Fig. 4C and Supplemental
Fig. S7) In the presence of mS* but in the absence of mF,
the hC5aR-mGFP focus stoichiometry showed an approx-
imately linear dependence on number of associated mS*
molecules, suggesting that each colocalized mS* molecule
wasassociated, onaverage,with;4–5hC5aRmolecules. In
the presence of mF* or unlabeled mF, no dependence was
observed (Supplemental Fig. S7; R2 , 0) consistent with a
random association between toxin and receptor. These re-
sults areunlikely tobea result of fluorescencequenching, as
itwouldneed tobenear 100%quenching todetect noAlexa
Fluor fluorescence in thehC5aR-mGFP foci, and thedrop in
colocalization is observed independent of the labeled toxin
used, either mS* with mF or mF* with mS.
Live whole-cell FRET and biochemical
measurements also support
LukSF disassociation
We performed FRET experiments on FITC sortase-
labeled hC5aR and Cy3 mS* or mF*, as donor and ac-
ceptor, respectively, in live cells to probe further the
association between toxin and receptor. A FRET signal
from whole cells of 75% efficiency was observed, with a
statistically significant drop (P = 0.008, Student’s t test) to
56% when incubated with unlabeled mF (Fig. 4D, E), as
would be expected if the complex formation leads to dis-
sociationof the toxin from the receptor. To examinepossible
FRET between hC5aR and Cy3 mF*, we performed similar
experiments on fixed cells. In these experiments, a FRET
efficiency of 60% was observed between hC5aR and mS*,
dropping below 40% (P = 0.023, Student’s t test) between
hC5aR and mF*. As expected, no FRET signal was ob-
served in the negative control, where only Cy3 mF* was
present. These results are also consistentwith the finding
that hC5aR dissociates from the LukSF pore, although
conformational or local environment changes cannot
be ruled out with FRET alone, as the relatively high
remaining signal might, in principle, also indicate
remaining association or other inter- or intra-hC5aR–
Luk interaction. The greater drop in FRET when mea-
sured with mF compared with mS might be caused by
the 3–4 nm further distance of LukF from hC5aR.
To confirm further that the LukSF complex dissociates
from the target receptor, we used a PE-labeled anti-CD88
mAb todetect the liberation of free hC5aR receptors on the
cellmembrane upon LukSF formation.We first confirmed
the ability of both C5a and S(wt) to compete for binding of
the anti-CD88 antibody to the hC5aR-expressing HEK
cells. Both ligands showed clear inhibition of anti-CD88
binding at 100 nM concentrations, whereas F(wt) was in-
effective (Fig. 5A). However, when the hC5aR-expressing
cells were incubated with 100 nM S(wt), followed by in-
cubation with increasing concentrations of F(wt) to form
an active toxin, a statistically significant increase in anti-
CD88 binding was detected at a F(wt) concentration of
1 nMwhen comparedwith no F(wt) (0 nM). Addition of a
control protein Ecb did not change anti-CD88 binding.
Cell permeabilization was measured in parallel and
proved to be “sublytic,” enabling proper detection of
liberated anti-CD88 without significant cell lysis (percent
of lysed cells,10%; Fig. 5B). At a 3 nMF(wt) concentration,
the proportion of dead cells increased above 10%, which
determinedthemaximumconcentrationandincrease inanti-
Figure 5. LukSF dissociation and rebinding of C5a on hC5aR-
expressing cells. A) Inhibition of anti-CD88 binding on hC5aR-
expressing HEK cells using increasing concentrations (x axis)
of S(wt) and C5a; F(wt) is used as a negative control for
inhibition of anti-CD88 binding (number of biologic repeats,
n = 2). The values are normalized against the maximum binding
observed with only anti-CD88. B) Disengagement of hC5aR
from LukSF was observed as an increase in PE-conjugated anti-
CD88 binding (right y axis, indicated with bars) on S(wt)-
precoated cells using increasing but sublytic concentrations
(x axis, indicated with dots) of F(wt). The values are normalized
against the maximum binding observed with S(wt)-incubated
cells with only anti-CD88. Minimal cell lysis (percent of lysed
cells, left y axis) detected in F(wt) concentrations below 3 nM (n
= 3). C) Rebinding of constant amount of NT647-labeled C5a
on hC5aR upon LukSF formation, analyzed by incubating S(wt)-
precoated cells with increasing concentrations (x axis) of LukF
mutant F(G130D) that associates with LukS but does not lead to
cell lysis (n = 2). The values are normalized against the
maximum binding observed with only NT647-C5a. D) Effect of
LukSF-mediated cell lysis on complement activation and
C5a formation on full blood measured by using C5b-9 as a
marker for complement activation in plasma (n = 3). Maximal
C5a formation is observed by the incubation of full blood
with live S. aureus bacteria. Ecb (B, C), F(wt) (A), or S(wt) (D) is
used as a negative control in the assays. Percentages of mean
ﬂuorescence intensities is shown as relative to the maximal
intensity in each individual experiment (A–C). Statistical signif-
icances are calculated using Student’s t test. Error bars indicate
SD.
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CD88 binding that could be measured. The changes in
C5aR mobility, colocalization, and FRET, with addition
of LukF, combined with the biochemical evidence of
anti-CD88 rebinding on hC5aR upon F(wt) addition on
S(wt)-coated cells, are strongly indicative of disassocia-
tion of the LukSF complex.
Dissociation of LukSF pores from hC5aR
allows rebinding of C5a
As C5a is the natural ligand for hC5aR and can out-
compete binding of LukS on the receptor, we next ana-
lyzed whether LukSF formation and disengagement of
hC5aR would allow rebinding of C5a on the receptor. We
specifically chose to analyze binding of labeled C5a and
not LukS in the presence of increasing concentrations of
LukF. This is because the addition of labeled LukS to cells
coatedwithLukS (and thenwashing), togetherwithLukF,
will give several possibilities for association: for example,
new pores for free or unoccupied C5aR, intercalationwith
present-bound LukS and LukF in pores, and binding to
free or unoccupied C5aR but without pore formation. To
detect C5a rebinding at higher LukF concentrations, we
used a F(G130D)mutant that interactswith LukS but does
not cause cell lysis. Nonlytic activity of this mutant in this
assay was confirmed by DAPI staining that showed mini-
mal cell lysis even at higher concentrations [9% at a 300 nM
F(G130D) concentration]. At a 300 nM concentration, a
significant increase inC5abindingwasdetected, indicating
thatLukSFdissociates fromhC5aR, enabling simultaneous
rebinding of an hC5aR-interacting ligand (Fig. 5C). On the
contrary, addition of the control molecule, Ecb, did not
cause an increase inC5abinding, suggesting that thiswas a
result of rebindingofC5a todisengagedhC5aRandnot, for
example, because of an increase in receptor expression.
This assay showed that C5a can potentially interact with
these cells that are attacked by LukSF. Because the hC5aR
expression levels of unstimulated human PMNs were
comparatively low (Supplemental Fig. S2) and because
these cells express another LukS-binding receptor—
hC5aR2—we tested whether the rebinding of anti-CD88
could be detected on these S(wt)-precoated cells in the
presence of increasing concentrations of F(G130D) (Sup-
plemental Fig. S9). As a reference also, the rebinding of
anti-CD88 on HEK-hC5aR cells was analyzed. As expec-
ted, a significant increase on anti-CD88 S(wt)-precoated
HEK-hC5aR cells was detected in a 300 nM concentration
of F(G130D). Despite low hC5aR expression levels and
possible competitive binding of S(wt) by hC5aR2, a slight
increase of anti-CD88 was also detected on S(wt)-
precoated PMNs. As C5a is a potent anaphylatoxin that
is generated during complement activation and poten-
tially plays a crucial role in S. aureus infections (55), we
next analyzed whether LukSF could lead to complement
activationandC5a formation in an exvivo full bloodassay.
We used soluble C5b-9 as a marker for terminal comple-
ment activation and C5a formation, not C5a, as LukS is
known to compete with C5a for binding to hC5aR on
neutrophils (18). The presence of 200 nM S(wt)F(wt)
clearly increased formation of soluble C5b-9 compared
with full blood without any toxin or only S(wt) (Fig. 5D),
indicating that LukSF-mediated cell lysis increases C5a
formation and potentially also inflammation in the site of
infection.
DISCUSSION
To determine the stoichiometry of the toxin components
without immobilizing the protein on a surface or within a
crystal, we used single-molecule imaging of the actual
pore formation mechanism within a living cell, including
the target receptor crucial for the complex formation. This
kind of study on protein complex formation has not been
done before, primarily as a result of the difficulty of la-
beling the components and the high native fluorescence
background in mammalian cells. Our covalent labeling
strategy and high excitation intensity TIRF microscopy,
combined with advanced image analysis tools, open the
way for further studies into many other pore-forming
toxins and processes involving membrane-bound protein
complex formation.
The finding that the toxin complexes are found in re-
ceptor clusters indicates that lysis of cells depends on the
localdensityofhC5aRs thatwill initiate thepore formation
process by docking LukS close to the cell membrane, such
that 4 hC5aR-LukS dimers (assuming that 1 LukS binds
only 1 hC5aR, although hC5aR are randomly clustered on
themembrane) can interact with the free, nonboundLukF
that will eventually form an octamer (i.e., 4 3 4) and a
functional porewith LukS. That hC5aRdisassociates from
complete pores leaves it free to interact with the C5a
formed during complement activation, amplified by
LukSF-mediated cell lysis itself. In addition to invading
microbes, apoptotic and necrotic cells are known to acti-
vate complement (56). The release of locally generatedC5a
(Fig. 5) and its interaction with adjacent cells, such as en-
dothelial or lung epithelial cells (57), could explain the
mechanism behind the exacerbated inflammation charac-
teristics exhibited in necrotizing pneumonia. This is an
important finding, suggesting that the cause of infection
candramatically affect themagnitude of the inflammatory
response and is highly dependent on the dynamics of
microbial molecules interacting with human receptors. In
addition, the disengaged hC5aR is possibly available for
new toxins to bind; although indirect, our findings suggest
that this may allow the receptor to be recycled and reused
by additional LukS molecules. Our finding that C5a can
rebindprovides indirect evidence that additionalLukScan
also bind.
To characterize the hC5aR interaction with LukSF at a
molecular level, we used maleimide-labeled toxins and
HEK cells, which expressed only hC5aR and not the sec-
ond docking target hC5aR2 for LukSF or CD45 for LukF,
that are all present on human PMNs (49, 58). We verified
that the interaction between maleimide-labeled toxin
component mS* and the cell-surface receptor is required
for the target recognition and cell lysis similarly, as shown
before for S(wt) (18), both for human PMNs and hC5aR-
expressing HEK cells that were chosen for TIRF imaging
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because of their stabilityandability to formmonolayerson
the microscopy coverslip.
With the characterization of the mobility of hC5aR and
LukS in live cells, we find that roughly half of hC5aR and
LukS foci diffuse relatively freely in the cell membrane,
whereas the remainder are confined to zones in the
membrane of ;400 nm effective diameter. However,
when LukF is present,.90% of LukS foci become immo-
bile (confined). If LukS were to undergo a conformational
change following LukF binding, then this may potentially
expose hydrophobic residues that could facilitate insertion
of the toxin into the hydrophobic interior foci of the
phospholipid bilayer. This stable insertion of the LukSF
complex into the cell membrane then leads to pore for-
mation across thewhole cellmembrane. This hypothesis is
strongly supported by the b-barrel prepore-pore forma-
tion putative mechanism of g-hemolysin. Here, the resi-
dues responsible for binding with the phospholipid head
group are located at the bottom of the rim domain,
whereas the stemdomain forms an antiparallelb-barrel of
which the bottom half comprises the transmembrane
portion of the pore (30). This change from the receptor-
associated LukS to the cell membrane-associated LukSF
complex can be seen as a change in the proportion of
mobile (receptor-associated LukS) and immobile (toxin
complexes inserted into cell membrane) foci detected in
live cells, unlikely to be mobile, as the b-hairpin of LukS
and LukF is inserted across the membrane during pore
formation and therefore, presumably provides a strong
anchor for the formationof a stablemembrane-permeating
pore. GPCRs similarly are known to have heterogeneous
mobility and lateral distribution properties in living cells
at different states, for example, before and after activation
(59).
Crystallographic evidence from the monomeric LukF
and LukS components and the intact g-hemolysin pore
suggests that the pore is octameric, formed from 4-plus-4
LukF/LukS subunits (29, 60, 61).Our findings support this
octamer model but unlike previous studies, also indicate
that LukSpreforms into a tetramerwithout LukF, and that
formation of this tetramer is facilitated by the close prox-
imity C5aR clusters. Based on the earlier scientific evi-
dence, it is known that LukS does not form homodimers,
and therefore, it is unlikely that these LukS molecules
interactwith each other in these clusters (29). Therefore, a
more plausible explanation is that LukS are sufficiently,
closely packed inside these clusters so as to enable a single
LukF tobind to2LukSmolecules simultaneouslyon2 sites
of LukF. The presence of LukS tetramers in the absence of
LukF cannot be further explained by our data. It is, how-
ever, possible that if LukS molecules would be associated
as a tetramer when bound on the receptor, then the con-
formational changes on LukS caused by interactions with
LukF should enable associationof theLukF subunits to the
complex. According to our findings presented here, this
scheme is possible, as in these assays, LukS was first en-
abled to bind to the receptors, and the effect of freshly
formed complexes by free, unboundLukSwas eliminated
by using a washing step before addition of LukF. Each
octamer component consists of cap, rim, and stem do-
mains. Here, the cap domain contains the site for LukS/
LukF interaction, whereas the stem domain unfolds and
forms the transmembrane b-barrel upon pore formation.
Within crystallization, the 2-methyl-2,4-pentanediol mol-
ecules are bound at the base of the rim domain and rec-
ognized by Trp177 and Arg198 residues that may
participate in recognition of the phospholipid bilayer, as
suggested in a crystal structure of the LukFmonomer (62).
In contrast, the structure of the g-hemolysin suggests
a membrane-interaction site within residues Tyr117,
Phe119, and Phe139 on the same toxin component (29).
The crystal structure of Luk components ED, determined
recently, reveals important details of the residues on Luk
component E required for receptor identification (63). This
component corresponds to the receptor-binding compo-
nent LukS on the LukSF complex, scanning mutagenesis,
indicating that LukS residues Arg73, Tyr184, Thr244,
His245, and Tyr250 and to a lesser extent, Tyr181, Arg242,
and Tyr246 are involved in binding to the neutrophil
surface (64).
These results suggest that further binding sites for
hC5aR on LukS could be possible in addition to those
identified in the LukS rim domain (64). However, as the
binding of LukS to neutrophils is inhibited by the C5a, it is
likely thatLukShasonly 1binding site on the receptor (20).
This is also supported by the similar inhibition profiles of
LukS and C5a toward anti-CD88 binding on hC5aR
shown in this study. Therefore, the association of LukS
with ;4–5 hC5aR molecules could be explained by the
previous suggestion that C5aR forms homo-oligomers in
living cells (65).Our findings imply thatLukSFassembly is
dependent on the hC5aR cell-membrane area density as
opposed to the effective hC5aR concentration when cal-
culated over the whole of a target cell volume, such that
even when hC5aR cellular expression levels are low, for
example, when inflammatory mediators are formed to
limit the inflammation (50), a cell lysis response may po-
tentially be achieved through the efficient targeting of re-
ceptor clusters and putative recycling of the receptor
molecules in the cell membrane to be reused by free,
nonboundLukS toget engaged inoctamerpore formation.
It is possible, in principle, that overexpression of hC5aRon
HEK cells could lead to an increased ability to formhC5aR
clusters, although expression levels arewithin the range of
those in activated neutrophils, exacerbated by the in-
tracellular GFP (although we used the mGFP variant).
Other studies, however, have shown that hC5aR forms
clusters of homodimers or heterodimers with the second
C5aR C5LR (C5aR2) or other GPCRs, such as CCR5, es-
pecially under high concentrations of C5a (47, 65, 66).
Previous in vitro studies on LukSF pores formed on
human leukocytes and rabbit erythrocytes have found
evidence for both octamers and hexamers, but impor-
tantly, both suggest a LukS:LukF ratio of 1:1 (17, 67, 68).
Interestingly, we did not observe any correlation to the
number of hC5aRpresentwith LukF incubation time once
LukF was already bound to LukS. Moreover, when LukS
was incubated with LukF, using sortase-labeled hC5aR
cells, a significant reduction was observed in the FRET
efficiency signal between LukS and C5aR. It is unlikely
that the reduction that was observed in FRET efficiency
would be a result of a conformational change, as the
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cysteine mutation used for maleimide labeling was
designed to be exposed on the cap domain of LukS and
LukF (Supplemental Fig. S1) that in light of the structural
data, undergo minimal or no conformational changes
during complex assembly (30). As our biochemical assays
indicate that LukF does not bind directly to hC5aR-
expressing cells and that bindingofLukF toLukS results in
an increased distance between the receptor and the com-
plex, this suggests that LukF binding to LukS results in
LukS dissociating from the receptor, released as a newly
formed LukSF complex.
We cannot directly determine the cause of disassocia-
tion in our present study; however, one explanation may
lie in the conformational change during the prepore-to-
pore transition that has been shown to occur on g-hemo-
lysin complexes subsequently after binding of LukF to
LukS (29, 30). Interestingly, this same study shows that
during the prepore state, the space for the transmembrane
region is occupied by the rim domain of the adjacent
octamer in a LukSF crystal. One explanation for these
observations that remains to be explored is that in addition
to the stem domain, the residues within the rim domain
that interact with the receptor might also have different
orientations in the prepore state when compared with the
pore state. In addition to using the maleimide-labeled
mLukF and mLukS and fluorescence microscopy, the
putative dissociation of the hC5aR from the LukSF com-
plex was further verified by using the S(wt) and F(wt)
proteins in an assay where LukS-coated hC5aR cells
were incubated with increasing concentrations of LukF.
Here, an increase in anti-CD88 binding also clearly indi-
cates LukSF dissociation. In all of the assays where we
could observe 20–30% receptor dissociation, we used
sublytic concentrations of LukF to be able to measure
Figure 6. Model for LukSF
receptor binding and the
mechanism of LukSF-induced
inﬂammation. A). LukS [Pro-
tein Data Bank identiﬁcation
(PDB ID): 1T5R] binds on
hC5aR (structure based on
angiotensin receptor data
PDB ID: 4YAY as a soluble
monomer on the cell mem-
brane. Each LukS monomer
binds 1 hC5aR molecule via
the receptor-interacting resi-
dues R73, Y184, Y250, and
T244 (marked with blue dots)
within a cluster of ;4–5
hC5aR homo-oligomers Upon
binding to hC5aR, LukS ex-
poses residues for LukF (PDB
ID: 1LKF) binding (interface
indicated by dashed ellipse).
In these tight clusters, each
LukF can bind to 2 LukS
monomers via 2 interfaces.
B) Binding of LukF on LukS
and formation of the octa-
meric pore (PDB ID: 3B07)
causes dissociation of the re-
ceptors from the complex
because of leakage of the cell
membrane and possibly also
because the receptor-binding
region (marked with a circle)
is buried between the mono-
mers in the complex. C) The
detached hC5aR molecule
can be reused by its ligands
LukS or C5a anaphylatoxin
(PDB ID: 1KJS). D) Zoom-
out of A–C, illustrating the
putative mechanism of LukSF-
induced inﬂammation. RBC,
red blood cell.
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healthy cells with normal membrane fluidity and natural
behavior rather than dead cells. This kind of receptor
disengagement has been shown before by at least the cy-
totoxin intermedilysin, which interacts with a GPI-
anchored complement regulatory molecule on the cell
membrane (69). Moreover, dissociation of the LukSF
complex is also supported by electron microscopy of
LukSF on human leukocyte membrane fragments. Here,
the ring-shapedoligomerswithouter 9 nmand inner 3 nm
diameters were shown without a receptor (68).
In this study, we also show for the first time to our
knowledge that the dissociated receptor can be reused by
free, unbound C5a. In our full blood model, we observed
that LukSF-mediated cell lysis clearly increased comple-
ment activation and C5a formation. The increase in C5a
concentration in the site of infection could potentially limit
the availability of hC5aR for LukS molecules on neutro-
phils and thereby, reduce lytic activity of the toxin, as C5a
has previously been shown to reduce LukSF-mediated
lysis in vitro (18). The rebindingofC5a on the receptormay
therefore indicate that in natural settings, where all com-
ponents (i.e., LukS, LukF, and C5a) are present, C5a can
outcompete binding of LukSF on the target cells. There-
fore, putative recycling of the receptor could be 1 strategy
for the toxin toensure that a sufficientnumberofporeswill
damage the cells, especially when a limited number of
receptors are available.
There are several steps on the Luk complex assembly
that may be critical for the function of the toxin. Based on
our observations, we provide new information on Luk–
receptor interactions and propose 2 additional stages to
the processes of pore formation and the mechanism by
which LukSF potentially induces inflammation (Fig. 6A).
Stage 1 is the binding of LukS to hC5aR clusters. The first
step in this process is the target recognition of LukS
binding to the membrane receptor. Stage 2 is the binding
of 4 LukF molecules to 4 LukS molecules, resulting in a
hetero-octamer LukSF nanopore in the neutrophil cell
membrane. Stage 3 is then the dissociation of the receptors
from the LukSF complex, enabling the receptor to be
reused for subsequent bindingof the free, unbound ligand
to generate more nanopores in the cell membrane and
enhance the damage to the neutrophil. In addition to
previous studies (14),wesuggest thatLukSF-mediatedcell
lysis and dissociation from hC5aR can potentially amplify
S. aureus-mediated inflammation in the site of infection
(Fig. 6). The direct lysis of neutrophils is enhanced by
newly formedLukSFcomplexes thatare formedon thecell
membrane hC5aR via reattachment of new LukS. Neu-
trophil lysis activates the complement system, and the
newly generated C5a induces cytokine/chemokine pro-
duction and neutrophil chemotaxis via the C5a/C5aR
signaling pathway on adjacent cells. Furthermore, the in-
creased vasodilation and vascular permeability (Fig. 6B)
leads to massive neutrophil accumulation and tissue in-
jury at the site of bacterial infection (70).
In summary, our findings that the receptors of targeted
host cells dissociate rapidly from the Luk complex upon
formation of a harmful toxin pore, freeing up mobile re-
ceptor seeds that can diffuse to other parts of the cell
membrane, suggest a hitherto undiscovered strategy used
by microbes to kill human immune cells. This putatively
enables a limited number of receptors to be recycled as
docking for the Luk or potentially the anaphylatoxin C5a
to ensure that enough pores will form to damage the host
cell and simultaneously maintain or possibly amplify the
inflammation in the site of infection. This discovery may
generalize to other bicomponent toxins that use a similar
docking receptor, such as theC5aR receptor, including the
family of Staphylococcal bicomponent Luk of HlgC/HlgB,
HlgA/HlgB, LukE/LukD (CXC chemokine receptors 1
and 2 and CCR5), and LukM/LukF9 for bovine CCR2.
These results highlight the importance of Luk-receptor
interactions in pore formation and may facilitate further
understanding of the role of pore-forming toxins in S.
aureus infections. This newmechanistic insight may prove
valuable to the development of future antibacterial and
anti-inflammatory therapies, especially important in lightof
the growing menace of global antimicrobial resistance.
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